C ao Longxiang is the chairman of Hubei Jumpcan Pharmaceutical, a leading Chinese drug manufacturer known for its pediatric and traditional Chinese medicine (TCM) products. His path to wealth began in the industrial sector; he was a manager at a cement factory and served in the military before transitioning to pharmaceuticals. He took the helm of what was then a general machinery company and steered its transformation into a pharmaceutical powerhouse, officially taking control in 2013.

Under Cao's direction, Jumpcan has focused on developing flagship products like Pudilan Anti-inflammatory Oral Liquid, which have become staples in Chinese healthcare. He owns more than 60% of the company, ensuring strong family control over its strategic direction. His son, Cao Fei, serves as vice chairman, preparing for the next generation of leadership. The company's success on the Shanghai Stock Exchange reflects the robust demand for modern TCM treatments in China.

Quick Reads:

• Chairman of Hubei Jumpcan Pharmaceutical.
• Transformed the company from a machinery firm into a pharma giant.
• Specializes in traditional Chinese medicines, particularly for children.
• Served in the Chinese military and worked in cement before pharma.
• His son, Cao Fei, is the company's Vice Chairman.